Description
BIDxone-S Injection is a broad-spectrum antibacterial formulation containing Ceftriaxone and Sulbactam, designed to provide enhanced antimicrobial activity against susceptible bacteria. Ceftriaxone belongs to the third generation cephalosporin class of antibiotics and is widely used in the treatment of moderate to severe bacterial infections.
However, certain bacteria produce enzymes known as beta-lactamases, which can reduce the effectiveness of antibiotics like ceftriaxone. Sulbactam acts as a beta-lactamase inhibitor that blocks these enzymes, thereby protecting ceftriaxone from degradation and restoring its antibacterial activity. This synergistic combination improves the effectiveness of the antibiotic therapy against resistant strains of bacteria.
BIDxone-S Injection is widely used in hospitals and healthcare facilities for the treatment of various infections caused by susceptible microorganisms. The formulation is administered intravenously (IV) or intramuscularly (IM) under the supervision of qualified healthcare professionals.
Dosage and Administration
BIDxone-S Injection should be administered only under the supervision of a qualified healthcare professional.
-
Can be administered by Intravenous (IV) or Intramuscular (IM) route.
-
Dosage and duration of treatment depend on the type and severity of infection, patient condition, and clinical response.
-
Reconstitution should be performed using the recommended sterile diluent before administration.
Safety Information
-
For prescription use only.
-
Use under the guidance of a registered medical practitioner.
-
Not recommended for patients with known hypersensitivity to cephalosporins, penicillins, or beta-lactam antibiotics.
-
Consult a healthcare professional before use in pregnant or lactating women.

